CLINICAL_TRIALS
trial_result
· 2016-09-05
Clinical Trial Update: Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus
Summary
A Yale-sponsored clinical trial evaluating whether stress hyperglycemia can serve as an indicator for type 2 diabetes has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yale University | Conditions: Stress Hyperglycemia, Diabetes Mellitus Type 2 | Status: TERMINATED